Agalsidase-Beta Therapy for Advanced Fabry Disease
Figure 3.Hazard ratios for the primary end point stratified by median baseline serum creatinine level, estimated glomerular filtration
rate (eGFR), and proteinuria.
Proteinuria denotes the urine protein–creatinine ratio. The P values for formal tests for treatment interaction were as follows: baseline serum creatinine level, P = 0.16; baseline eGFR, P = 0.09; and baseline proteinuria, P = 0.54.